Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza-Reference-Cited by-同舟云学术

Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza

Published:2023-05 Issue:5 Volume:10 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Sorey Woody¹,Krantz Elizabeth M²,Morris Jessica²,Klaassen John²,Sweet Ania²³,Tverdek Frank²³,Escobar Zahra K²³,McCulloch Denise J¹²⁴,Pergam Steven A¹²⁴,Liu Catherine¹²⁴^ORCID

Affiliation:

1. School of Medicine, University of Washington , Seattle, Washington , USA

2. Fred Hutchinson Cancer Center , Seattle, Washington , USA

3. School of Pharmacy, University of Washington , Seattle, Washington , USA

4. Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington , USA

Abstract

Abstract Among 133 cancer outpatients diagnosed with influenza between 2016 and 2018, 110 (83%) were prescribed oseltamivir. Among 109 with a known symptom onset date, 53% presented for care and 31% were prescribed oseltamivir within 48 hours. Patient/provider education and rapid diagnostics are needed to improve early oseltamivir use among cancer patients with influenza.

Funder

NIH

NCI

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad254/50262617/ofad254.pdf

Reference18 articles.

1. Epidemiology and outcomes of serious influenza-related infections in the cancer population;Cooksley;Cancer,2005

2. Seasonal incidence of symptomatic influenza in the United States;Tokars;Clin Infect Dis,2018

3. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations;Kaiser;Arch Intern Med,2003

4. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults;Kaiser;Arch Intern Med,2000